Merck Sharp & Dohme B.V v. Dr. Reddys Laboratories, Inc

Court

District Court, D. New Jersey (D.N.J.)
Official Court Website →

Assigned judge

Claire C. Cecchi · 12,702 cases in index

Docket number

2:20-cv-02909

Nature of suit

835
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal question

Date filed

03/16/2020

Date terminated

08/24/2020

623 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Merck Sharp & Dohme B.V · 21 cases
• defendant · Dr. Reddys Laboratories, Inc Pharmaceuticals & Biotechnology · 36 cases

Part of a Larger Litigation Pattern

This is one of 37 Patent - ANDA cases in our index naming DR. REDDYS LABORATORIES, INC — a possible mass-tort or coordinated-litigation cluster.

• Bayer HealthCare Pharmaceuticals Inc v. Dr. Reddys Laboratories, Ltd
  District Court, D. DelawareFiled 10/23/2025
• Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc
  District Court, D. DelawareFiled 07/29/2021
• Merck Sharp & Dohme Corp v. Dr. Reddys Laboratories, Inc
  District Court, D. DelawareFiled 07/15/2021
• Bayer Pharma Ag v. Dr. Reddys Laboratories, Ltd
  District Court, D. DelawareFiled 05/24/2021
• AbbVie Inc v. Dr. Reddys Laboratories, Ltd
  District Court, D. DelawareFiled 07/21/2020
• Bristol-Myers Squibb Company v. Dr. Reddys Laboratories, Ltd
  District Court, D. New JerseyFiled 10/03/2019

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Merck Sharp & Dohme B.V v. Dr. Reddys Laboratories, Inc?

Merck Sharp & Dohme B.V v. Dr. Reddys Laboratories, Inc is a federal patent - anda lawsuit filed on 03/16/2020 in the District Court, D. New Jersey. The case was terminated on 08/24/2020. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. New Jersey, docket number 2:20-cv-02909.

When was the case filed?

Merck Sharp & Dohme B.V v. Dr. Reddys Laboratories, Inc was filed on 03/16/2020. It was terminated on 08/24/2020.